Bespoke Extracts (BSPK) Profit After Tax Growth (5y) (2016 - 2021)
Bespoke Extracts (BSPK) Profit After Tax Growth (5y) (2016 - 2021) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn |
| 10 | Bespoke Extracts | 1.12 Mn | 1.11 Mn | 234,175.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Nov 30, 2021 | 48.99% |
| Aug 31, 2021 | 131.43% |
| May 31, 2021 | -34.03% |
| Feb 28, 2021 | -11.05% |
| Nov 30, 2020 | -20.04% |
| May 31, 2020 | -123.52% |
| Feb 29, 2020 | -47.84% |
| Nov 30, 2019 | -51.20% |
| Aug 31, 2019 | -32.26% |
| May 31, 2019 | -39.28% |
| Feb 28, 2019 | -28.66% |
| Nov 30, 2018 | 115.81% |
| Aug 31, 2018 | -97.70% |
| May 31, 2018 | -107.43% |
| Feb 28, 2018 | -83.49% |
| Nov 30, 2017 | -63.30% |
| May 31, 2017 | -84.01% |
| Feb 28, 2017 | 22.60% |
| Nov 30, 2016 | 31.51% |
| Aug 31, 2016 | 24.29% |